SCHEMBL5501768

SCHEMBL5501768

O=C(O)c1cccc(OCOCc2ccccc2)c1

nearest known ligand 0.77

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 8/20 0.77
NR1H4 Q96RI1 2/20 0.64
SRD5A2 P31213 1/20 0.63
MAOB P27338 1/20 0.60
MRGPRX4 Q96LA9 4/20 0.59
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
SMPD1 P17405 1/20 0.57
NR4A1 P22736 1/20 0.57
NR4A3 Q92570 1/20 0.57
FFAR1 O14842 1/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8697768 0.88 MAOB (0.78) NR4A2NR1H4SRD5A2MAOBMEN1
SCHEMBL30207018 0.87 NR4A2 (1.00) NR4A2NR1H4SRD5A2MAOBMRGPRX4
SCHEMBL339009 0.87 NR4A2 (1.00) NR4A2NR1H4SRD5A2MAOBMRGPRX4
SCHEMBL1123155 0.86 NR4A2 (0.91) NR4A2NR1H4SRD5A2MAOBMRGPRX4
SCHEMBL28768851 0.86 MAOB (0.58) NR4A2NR1H4SRD5A2MAOBMRGPRX4
Hydrochloric Acid SCHEMBL4748074 0.86 NR4A2 (0.97) NR4A2NR1H4SRD5A2MAOBMRGPRX4
SCHEMBL1122713 0.84 NR4A2 (0.94) NR4A2NR1H4SRD5A2MAOBMRGPRX4
SCHEMBL20472362 0.83 NR4A2 (0.69) NR4A2NR1H4SRD5A2MAOBMRGPRX4
SCHEMBL5017852 0.82 PLA2G4B (0.56) NR4A2MAOBKMT2ASMPD1FFAR1
SCHEMBL4138759 0.81 NR4A2 (0.81) NR4A2MRGPRX4RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751097-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES Proteotech, Inc. (US) 2007-02-14 EP disclosed
WO-2005113489-A1 SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES PROTEOTECH, INC. (US) 2005-12-01 WO disclosed